昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06127 昭衍新药

未开盘 07-30 16:08:08

25.450

-2.500

-8.94%

最高28.600	最低25.200	成交量1,731万
今开27.350	昨收27.950	日振幅12.16%
总市值190.62亿	流通市值30.29亿	总股本7.49亿
成交额4.65亿	换手率14.54%	流通股本1.19亿
市净率2.16	ROE4.77%	每股收益0.11
52周最高28.700	52周最低6.298	市盈率233.80
股息0.03	股息收益率0.00	ROA0.46%

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":25.45,"timestamp":1753862888507,"preClose":27.95,"halted":0,"volume":17308241,"delay":0,"floatShares":119000000,"shares":749000000,"eps":0.10885601036066091,"marketStatus":"未开盘","change":-2.5,"latestTime":"07-30 16:08:08","open":27.35,"high":28.6,"low":25.2,"amount":464827951,"amplitude":0.121646,"askPrice":25.5,"askSize":17500,"bidPrice":25.45,"bidSize":44400,"shortable":0,"etf":0,"ttmEps":0.5568757807621366,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753925400000},"marketStatusCode":0,"adr":0,"listingDate":1614268800000,"exchange":"SEHK","adjPreClose":27.95,"dividendRate":0.001179,"openAndCloseTimeList":[[1753839000000,1753848000000],[1753851600000,1753862400000]],"volumeRatio":1.8146291545669844,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":33.42,"timestamp":1753858800000,"preClose":35.18,"halted":0,"volume":61373800,"delay":0,"premium":"-30.04"}},"requestUrl":"/m/hq/s/06127","defaultTab":"news","newsList":[{"id":"2555016882","title":"智通AH统计|7月30日","url":"https://stock-news.laohu8.com/highlight/detail?id=2555016882","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555016882?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:15","pubTimestamp":1753863307,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止7月30日收盘，东北电气、弘业期货、复旦张江分列AH溢价率前三位，溢价率分别为743.75%、227.43%、209.05%；宁德时代、恒瑞医药、招商银行分列AH溢价率末三位，溢价率分别为-20.05%、-3.78%、2.23%。其中安德利果汁、金力永磁、钧达股份的偏离值位居前三，分别为22.99%、20.11%、17.87%；另外，东北电气、中州证券、国联民生的偏离值位居后三，分别为-187.10%、-46.82%、-39.59%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323599.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02611","01065","00187","03678","02899","01033","01375","01288","159982","LU2097828805.USD","01456","02338","01057","00042","06185","LU0314109678.HKD","LU1880383440.USD","01349","01812","02238","03606","BK1583","06881","LU0516423091.SGD","LU0918141705.HKD","06680","01055","00300","02628","02039","399300","01276","03143","LU1008478684.HKD","BK1507","06178","03750","BK1576","03968","02727","02218","02603","06066","00991","LU2097828474.EUR","LU0384037296.USD","02865","06127"],"gpt_icon":1},{"id":"2555031941","title":"昭衍新药(06127)A股股票交易异常波动 不存在应披露而未披露的重大信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2555031941","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555031941?lang=zh_cn&edition=full","pubTime":"2025-07-29 17:31","pubTimestamp":1753781500,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)公布，公司A股股票于 2025 年 7 月 25 日、7 月 28 日和 7 月 29 日连续 3 个交易日内日收盘价格涨幅偏离值累计超过 20%。根据《上海证券交易所交易规则》的有关规定，属于股票交易异常波动情形。经公司自查并书面征询公司控股股东及实际控制人，截至本公告披露日，公司及公司控股股东、实际控制人确认不存在应披露而未披露的重大信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323156.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","159982","BK1141","BK0216","399300","06127","603127"],"gpt_icon":0},{"id":"2555503902","title":"7月29日昭衍新药（603127）龙虎榜数据：机构净卖出1.26亿元（3日），北向资金净卖出8995.54万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2555503902","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555503902?lang=zh_cn&edition=full","pubTime":"2025-07-29 17:14","pubTimestamp":1753780464,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年7月29日公布的交易公开信息显示，昭衍新药因非ST、*ST和S证券连续三个交易日内收盘价格涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月29日收盘，昭衍新药报收于35.18元，上涨9.94%，换手率7.79%，成交量49.1万手，成交额16.51亿元。从龙虎榜公布的三日买卖数据来看，机构合计净卖出1.26亿元，北向资金合计净卖出8995.54万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900028587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1576","BK1141","06127","603127"],"gpt_icon":0},{"id":"2555356330","title":"7月29日昭衍新药涨9.94%，易方达创新驱动灵活配置混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2555356330","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555356330?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:15","pubTimestamp":1753776931,"startTime":"0","endTime":"0","summary":"证券之星消息，7月29日昭衍新药涨9.94%创60日新高，收盘报35.18元，换手率7.79%，成交量49.1万手，成交额16.51亿元。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为易方达基金的易方达创新驱动灵活配置混合。易方达创新驱动灵活配置混合目前规模为18.2亿元，最新净值1.498，较上一交易日上涨1.77%，近一年上涨16.85%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900026213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK1576","603127","06127","BK0216"],"gpt_icon":0},{"id":"2555828710","title":"全线大张！三大利好刺激，创新药赛道大爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2555828710","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555828710?lang=zh_cn&edition=full","pubTime":"2025-07-29 13:50","pubTimestamp":1753768228,"startTime":"0","endTime":"0","summary":"创新药赛道大爆发。7月29日，A股、港股市场创新药板块再度全线爆发，多只个股大涨超10%。消息面上，创新药赛道大涨主要受业绩超预期、海外大订单与政策三大利好驱动。光大证券指出，考虑到部分创新药公司BD交易持续催化、细分赛道及正处于转型阶段的公司或有积极变化，应当积极关注板块高质量标的、增加板块配置。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507291350409724b29a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507291350409724b29a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","603229","LU2495084118.USD","BK0028","01177","06127","BK0060","03347","GSK","LU0405327494.USD","00853","LU2148510915.USD","LU1064130708.USD","BK0188","LU1328615791.USD","159992","01093","LU1969619763.USD","01530","LU1064131003.USD","02359","BK0183","603259","688321","LU1655091616.SGD","LU1997244956.HKD","LU2328871848.SGD","688221","LU1997245177.USD","01276","603367","LU0405327148.USD","603127","BK0012","LU2488822045.USD","02186","600276","BK0239","LU1997245094.SGD","BK0196","02096","603456","SBHMY"],"gpt_icon":0},{"id":"2555562089","title":"港股异动 | CRO概念持续走强 药明康德(02359)中报强劲且上调全年指引 机构看好板块迎戴维斯双击","url":"https://stock-news.laohu8.com/highlight/detail?id=2555562089","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555562089?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:29","pubTimestamp":1753759782,"startTime":"0","endTime":"0","summary":"消息面上，药明康德发布2025年上半年业绩，公司实现收入207.99亿元，同比增加20.6%；母公司持有者的应占净溢利82.87亿元，同比增加95.5%。值得一提的是，药明康德宣布上调全年业绩指引，公司预计2025年持续经营业务收入重回双位数增长，增速从10-15%上调至13-17%；同时，预计全年整体收入从人民币415-430亿元上调至人民币425-435亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1794554557.SGD","LU1997245094.SGD","LU2488822045.USD","LU0417516738.SGD","LU2495084118.USD","LU0516422366.SGD","LU0181495838.USD","LU2242644610.SGD","LU0516422440.USD","LU1720050803.USD","03759","BK1141","LU0359201612.USD","LU2039709279.SGD","LU0359202008.SGD","06127","SG9999002463.SGD","LU0708995583.HKD","LU0856984785.SGD","LU0348825331.USD","IE00B0JY6N72.USD","LU0043850808.USD","LU0052750758.USD","LU0588546209.SGD","LU2125910500.SGD","BK1521","LU0348735423.USD","LU0516423174.USD","LU1688375341.USD","BK0216","BK1589","LU1997244956.HKD","LU2045819591.USD","LU2328871848.SGD","LU1969619763.USD","BK1576","03347","LU0456842615.SGD","LU0320764599.SGD","603259","LU0417516902.SGD","LU0456846285.SGD","LU1242518857.USD","LU0516422952.EUR","02359","BK1610","LU0327786744.USD","LU0307460666.USD","SG9999002562.SGD"],"gpt_icon":1},{"id":"2555083933","title":"医疗服务行业盘中拉升，药石科技涨6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555083933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555083933?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:40","pubTimestamp":1753753248,"startTime":"0","endTime":"0","summary":"07月29日，医疗服务行业盘中拉升，截至09点40分，医疗服务行业整体指数上涨2.00%，报6708.100点。从个股上来看，该行业的成分股中，药石科技涨6.55%，药明康德、昭衍新药、海特生物涨幅居前。从资金上来看，截止发稿，医疗服务行业主力净流入为-8908.10万，其中凯莱英受到资金热捧，主力净流入2360.82万；拉长时间线来看，该板块近20日主力资金净流入-31.40亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729094048a46897b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729094048a46897b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","603127","603259","LU2328871848.SGD","LU1997244956.HKD","LU2495084118.USD","LU1997245177.USD","BK0229","LU2488822045.USD","LU0456842615.SGD","LU1997245094.SGD","02359","LU1969619763.USD","300725","06127"],"gpt_icon":0},{"id":"2555008810","title":"细胞免疫治疗概念盘中拉升，昭衍新药涨2.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555008810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555008810?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:38","pubTimestamp":1753753092,"startTime":"0","endTime":"0","summary":"07月29日，细胞免疫治疗概念盘中拉升，截至09点38分，细胞免疫治疗概念整体指数上涨0.54%，报1016.200点。从个股上来看，该概念的成分股中，昭衍新药涨2.75%，和元生物、ST八菱、复星医药涨幅居前。从资金上来看，截止发稿，细胞免疫治疗概念主力净流入为-2.18亿，其中达安基因受到资金热捧，主力净流入579.11万；拉长时间线来看，该板块近20日主力资金净流入-39.32亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072909381294c06685&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072909381294c06685&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0239","02196","BK0096","603127","688238","BK0175","600196","BK0187","BK0188","BK0216","BK0028","06127","BK0012","BK0183","BK0060"],"gpt_icon":0},{"id":"2554728724","title":"昭衍新药盘中异动 下午盘大幅拉升5.12%报25.650港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554728724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554728724?lang=zh_cn&edition=full","pubTime":"2025-07-28 13:27","pubTimestamp":1753680462,"startTime":"0","endTime":"0","summary":"2025年07月28日下午盘13时27分，昭衍新药股票出现异动，股价大幅上涨5.12%。截至发稿，该股报25.650港元/股，成交量533.544万股，换手率4.48%，振幅7.99%。资金方面，该股资金流入6032.57万港元，流出4855.2万港元。昭衍新药股票所在的生物技术行业中，整体涨幅为1.34%。其相关个股中，北海康成-B、方达控股、三叶草生物-B涨幅较大，振幅较大的相关个股有北海康成-B、方达控股、奥星生命科技，振幅分别为20.51%、18.18%、14.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728132742a6c54369&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728132742a6c54369&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","06127","BK1576"],"gpt_icon":0},{"id":"2554773796","title":"医药板块也“反内卷”！CXO、医疗器械接棒反攻，创新药ETF天弘(517380)、医疗设备ETF(159873)涨超1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554773796","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554773796?lang=zh_cn&edition=full","pubTime":"2025-07-25 10:24","pubTimestamp":1753410246,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["515120","159646","BK0060","000808.SH","06178","163118","09996","159982","601788","02196","399441","512290","06978","06127","03759","300122","09939","YANG","02269","300869","159992","603127","159217","159883","399300","HSCEI","159399","688271","603976","159859","CXO","300760","09997","BK1515","07226","159938","300759","HSTECH","159891","300832","FDN","LU0979878070.USD","159645","159873","CXO.AU","161726","688626","600196"],"gpt_icon":0},{"id":"2554732672","title":"细胞免疫治疗概念盘中拉升，博腾股份涨10.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554732672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554732672?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:53","pubTimestamp":1753408396,"startTime":"0","endTime":"0","summary":"07月25日，细胞免疫治疗概念盘中拉升，截至09点53分，细胞免疫治疗概念整体指数上涨1.00%，报1024.710点。从个股上来看，该概念的成分股中，博腾股份涨10.86%，昭衍新药、阳光诺和、阳普医疗涨幅居前。从资金上来看，截止发稿，细胞免疫治疗概念主力净流入为-2.79亿，其中博腾股份受到资金热捧，主力净流入1722.65万；拉长时间线来看，该板块近20日主力资金净流入-27.46亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725095316a462398d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725095316a462398d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","300363","06127","688621","BK0239","603127","BK0216"],"gpt_icon":0},{"id":"2553223208","title":"昭衍新药07月24日获主力加仓949.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553223208","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553223208?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:15","pubTimestamp":1753344927,"startTime":"0","endTime":"0","summary":"07月24日, 昭衍新药股价涨6.79%，报收22.80元，成交金额1.4亿元，换手率5.15%，振幅7.96%，量比0.93。昭衍新药今日主力资金净流入949.7万元，上一交易日主力净流入1646.6万元。该股近5个交易日上涨4.84%，主力资金累计净流入1803.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2899.3万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165320a460e9e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724165320a460e9e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2553296147","title":"重回3600点，牛市“旗手”涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2553296147","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553296147?lang=zh_cn&edition=full","pubTime":"2025-07-23 12:57","pubTimestamp":1753246656,"startTime":"0","endTime":"0","summary":"7月23日上午，A股三大指数震荡拉升，沪指站上3600点，截至午间收盘，沪指涨0.75%，深成指涨0.31%，创业板指涨0.72%。CRO板块震荡拉升CRO板块震荡拉升，昭衍新药涨停，美迪西、博腾股份、皓元医药等涨超5%。山大电力一度涨超500%7月23日，两只新股首发上市，创业板山大电力一度涨超500%。此外，技源集团今日在上交所主板上市，开盘一度涨超370%，截至发稿，N技源涨280%，总市值为166亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072313032797b1cd18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072313032797b1cd18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601288","688131","02601","LU0287142896.SGD","BK1560","600864","01288","ACGBF","LU0173614495.USD","601696","688202","LU2039709279.SGD","LU1813983027.USD","603127","BK1231","601601","601665","LU1328277881.USD","BK1521","LU0314109678.HKD","03143","06127"],"gpt_icon":0},{"id":"2553260061","title":"CRO概念持续走强 昭衍新药涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2553260061","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553260061?lang=zh_cn&edition=full","pubTime":"2025-07-23 10:21","pubTimestamp":1753237266,"startTime":"0","endTime":"0","summary":"人民财讯7月23日电，CRO概念持续走强，截至发稿，美迪西涨超15%，昭衍新药涨停，康龙化成、博腾股份、凯莱英等跟涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723102106954de202&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"3a2cf9bd91f85ad98177b3a6685c0c95","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723102106954de202&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","603127","06127","BK0216","06821","688202"],"gpt_icon":0},{"id":"2553260752","title":"异动快报：昭衍新药（603127）7月23日10点14分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2553260752","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553260752?lang=zh_cn&edition=full","pubTime":"2025-07-23 10:15","pubTimestamp":1753236926,"startTime":"0","endTime":"0","summary":"证券之星7月23日盘中消息，10点14分昭衍新药触及涨停板。目前价格28.25，上涨10.01%。其所属行业医疗服务目前上涨。领涨股为海特生物。该股为CAR-T疗法，干细胞，基因编辑概念热股，当日CAR-T疗法概念上涨2.09%，干细胞概念上涨2.02%，基因编辑概念上涨1.68%。7月22日的资金流向数据方面，主力资金净流出6962.52万元，占总成交额11.14%，游资资金净流入548.51万元，占总成交额0.88%，散户资金净流入6414.01万元，占总成交额10.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072300011715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","603127","BK0216","BK1576","06127"],"gpt_icon":0},{"id":"2553588298","title":"上半年盈利翻倍！CXO强劲反弹，昭衍新药飙升8%！A股最大医疗ETF（512170）冲高2%再刷阶段新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2553588298","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553588298?lang=zh_cn&edition=full","pubTime":"2025-07-23 10:13","pubTimestamp":1753236780,"startTime":"0","endTime":"0","summary":"医疗板块突围进行时！7月23日早盘，CXO概念强势反弹，昭衍新药劲涨超8%，康龙化成涨超6%，凯莱英、九洲药业、泰格医药、药明康德等均大幅跟涨。　　A股最大医疗ETF盘中上探2%，盘中价再刷近4个月新高！场内交投活跃，开盘30分钟成交额突破4亿元。　　消息面，日前多家CXO龙头企业中报业绩预喜。昭衍新药上半年净利最高预增144%，药明康德亦预增超100%，康龙化成最高预增11%。　　还看好创新药，可以关注国内首只药ETF。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-07-23/doc-infhmnxu1352698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["512170","399300","BK0216","BK1576","159828","06127","CXO","603127","BK1141","159982"],"gpt_icon":0},{"id":"2553284719","title":"昭衍新药盘中异动 下午盘快速跳水5.12%报20.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553284719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553284719?lang=zh_cn&edition=full","pubTime":"2025-07-22 14:00","pubTimestamp":1753164035,"startTime":"0","endTime":"0","summary":"2025年07月22日下午盘14时00分，昭衍新药股票出现异动，股价急速下跌5.12%。截至发稿，该股报20.400港元/股，成交量349.741万股，换手率2.94%，振幅8.84%。资金方面，该股资金流入1942.72万港元，流出3468.43万港元。最近的财报数据显示，该股实现营业收入3.11亿港元，净利润4,455.80万港元，每股收益0.0542港元，毛利8,907.85万港元，市盈率191.14倍。昭衍新药股票所在的生物技术行业中，整体涨幅为0.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722140035a45b6d62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722140035a45b6d62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2552417302","title":"每周股票复盘：昭衍新药（603127）预计2025年上半年营收6.35亿至7.02亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2552417302","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552417302?lang=zh_cn&edition=full","pubTime":"2025-07-20 03:29","pubTimestamp":1752953349,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘，昭衍新药报收于26.62元，较上周的26.02元上涨2.31%。本周，昭衍新药7月14日盘中最高价报27.04元。7月15日盘中最低价报24.46元。昭衍新药当前最新总市值199.51亿元，在医疗服务板块市值排名7/50，在两市A股市值排名829/5149。本周关注点业绩披露要点：昭衍新药预计2025年1-6月营业收入6.35亿元至7.02亿元业绩披露要点昭衍新药发布业绩预告，预计2025年1-6月营业收入6.35亿元至7.02亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000000766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","06127"],"gpt_icon":0},{"id":"2552345131","title":"徐慕浩2025年二季度表现，泰信竞争优选混合基金季度涨幅1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552345131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552345131?lang=zh_cn&edition=full","pubTime":"2025-07-18 12:55","pubTimestamp":1752814528,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2025年二季度末，基金经理徐慕浩旗下共管理2只基金，本季度表现最佳的为泰信竞争优选混合，季度净值涨1.31%。徐慕浩在担任泰信竞争优选混合基金经理的任职期间累计任职回报145.76%，平均年化收益率为16.39%。持有期间的估算收益率为97.47%，持有期间东方盛虹在2020年到2021年的年报归属净利润增幅达496.75%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800017525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","06127","BK1141"],"gpt_icon":0},{"id":"2552643877","title":"昭衍新药07月17日获主力加仓1001.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552643877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552643877?lang=zh_cn&edition=full","pubTime":"2025-07-17 16:15","pubTimestamp":1752740156,"startTime":"0","endTime":"0","summary":"07月17日, 昭衍新药股价涨5.85%，报收21.70元，成交金额1.7亿元，换手率6.56%，振幅9.27%，量比0.81。昭衍新药今日主力资金净流入1001.0万元，上一交易日主力净流入961.5万元。该股近5个交易日上涨9.56%，主力资金累计净流入1861.6万元；近20日主力资金累计净流入2033.7万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717172021a6af7075&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717172021a6af7075&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","06127"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.192},{"period":"1month","weight":0.4626},{"period":"3month","weight":1.5938},{"period":"6month","weight":2.0175},{"period":"1year","weight":2.7498},{"period":"ytd","weight":1.7272}],"compareEarnings":[{"period":"1week","weight":-0.0141},{"period":"1month","weight":0.0459},{"period":"3month","weight":0.1382},{"period":"6month","weight":0.2448},{"period":"1year","weight":0.4807},{"period":"ytd","weight":0.2551}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.111186},{"month":2,"riseRate":0.75,"avgChangeRate":0.137943},{"month":3,"riseRate":0.4,"avgChangeRate":-0.007614},{"month":4,"riseRate":0.2,"avgChangeRate":-0.110118},{"month":5,"riseRate":0.8,"avgChangeRate":0.111301},{"month":6,"riseRate":0.6,"avgChangeRate":0.067356},{"month":7,"riseRate":0.8,"avgChangeRate":0.121581},{"month":8,"riseRate":0,"avgChangeRate":-0.164045},{"month":9,"riseRate":0.5,"avgChangeRate":0.001112},{"month":10,"riseRate":0.25,"avgChangeRate":-0.06138},{"month":11,"riseRate":0.5,"avgChangeRate":0.080696},{"month":12,"riseRate":0.5,"avgChangeRate":-0.057472}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}